Shay Capital’s Cellebrite CLBT Stock Holding History

Shay Capital’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-59,805	Closed	-$901K	–	515
2025 Q4	$1.08M	Buy	59,805 +30,944	+107%	+$556K	0.11%	179
2025 Q3	$535K	Buy	+28,861	New	+$453K	0.05%	245

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Shay Capital's CLBT Position: Q1 2026 in Review

Shay Capital sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 59,805 shares — an estimated $901K sold.

Shay Capital first reported a position in CLBT in Q3 2025 and held it in 2 quarters. The position peaked at $1.08M in Q4 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

Shay Capital reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
Shay Capital sold 59,805 Cellebrite shares in Q1 2026, an estimated $901K.
Shay Capital first reported a position in Cellebrite in Q3 2025 and held it in 2 quarters.
Shay Capital's Cellebrite position peaked at $1.08M in Q4 2025.
221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.